Home > Education & Research > Scientific & Clinical Research > Human Research Protection Program > Institutional Review Board (IRB)
The Essentia Health Institutional Review Board (IRB) reviews and evaluates proposed and ongoing human subjects research projects at Essentia Health to protect the rights and welfare of participants.
The IRB ensures research participants take part voluntarily and with safeguards from unnecessary or inappropriate risks in place. The IRB has also been designated to function as the privacy board under HIPAA requirements.
The IRB tracks the progress of every Essentia research project, even before participant recruiting takes place. At least once a year, the IRB reevaluates each project and works with the principal investigator and other sources to make modifications, if needed, to safeguard participants.
The Essentia Health IRB will include:
The Essentia IRB will:
Federal regulations guide the Essentia Health IRB composition, operation, and responsibilities for human research participant protection processes. The Department of Health & Human Services (HHS) Office for Human Rights Protections (OHRP) oversees IRB operations and the Food and Drug Administration (FDA) enforces regulations for the use of experimental drugs and devices.
Through its Federalwide Assurance (FWA), Essentia Health pledges to comply with the Protection of Human Subjects (45 CFR part 46) regulations.
For consideration on the Essentia Health IRB agenda, complete IRB submissions in iRIS at least 14 days before the meeting date. IRB staff recommend submitting well before the 14-day deadline to ensure your submission is complete.
The Essentia IRB meets monthly. The 2018 meeting dates are:
Download the Essentia Health IRB meeting dates and submission deadline dates [PDF].
Learn more about the institutional review board (IRB). Call 218-576-0711.
Email the IRB